The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial
Open accessAbstract
BACKGROUND: Pulmonary vein isolation (PVI) is the cornerstone of catheter ablation to treat patients with symptomatic drug-refractory atrial fibrillation (AF). OBJECTIVE: The purpose of this study was to assess the safety and efficacy of PVI using the cryoballoon catheter to treat patients with persistent AF. METHODS: STOP Persistent AF (ClinicalTrials.gov Identifier: NCT03012841) was a prospective, multicenter, single-arm, Food and Drug Administration-regulated trial designed to evaluate the safety and efficacy of PVI-only cryoballoon ablation for drug-refractory persistent AF (continuous episodes <6 months). The primary efficacy endpoint was 12-month freedom from ≥30 seconds of AF, atrial flutter (AFL), or atrial tachycardia (AT) after a 90-day blanking period. The prespecified performance goals were set at >40% and <13% for the primary efficacy and safety endpoints, respectively. Secondary endpoints assessed quality of life using the AFEQT (Atrial Fibrillation Effect on Quality of Life) and SF (Short Form)-12 questionnaires. RESULTS: Of 186 total enrollments, 165 subjects (70% male; age 65 ± 9 years; left atrial diameter 4.2 ± 0.6 cm; body mass index 31 ± 6) were treated at 25 sites in the United States, Canada, and Japan. Total procedural, left atrial dwell, and fluoroscopy times were 121 ± 46 minutes, 102 ± 41 minutes, and 19 ± 16 minutes, respectively. At 12 months, the primary efficacy endpoint was 54.8% (95% confidence [CI] 46.7%-62.1%) freedom from AF, AFL, or AT. There was 1 primary safety event, translating to a rate of 0.6% (95% CI 0.1%-4.4%). AFEQT and SF-12 assessments demonstrated significant improvements from baseline to 12 months postablation (P <.001). CONCLUSION: The STOP Persistent AF trial demonstrated cryoballoon ablation to be safe and effective in treating patients with drug-refractory persistent AF characterized by continuous AF episodes <6 months.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Approaches to catheter ablation for persistent atrial fibrillation
Verma, A., Jiang, C.-Y., Betts, T. R., Chen, J., Deisenhofer, I., Mantovan, R., Macle, L., Morillo, C. A., Haverkamp, W., Weerasooriya, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408288 · Cited by 2,339
Self-citationCryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
Kuck, K.-H., Brugada, J., Fürnkranz, A., Metzner, A., Ouyang, F., Chun, K. R. J., Elvan, A., Arentz, T., Bestehorn, K., Pocock, S. J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602014 · Cited by 1,950
Interpreting changes in quality of life in atrial fibrillation: How much change is meaningful?
Dorian, P., Burk, C., Mullin, C. M., Bubien, R., Godejohn, D., Reynolds, M. R., Lakkireddy, D. R., Wimmer, A. P., Bhandari, A., & Spertus, J. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.04.015 · Cited by 95 · cited 1×
“Similar to findings from previous cryoballoon PVI trials in patients with either paroxysmal AF or PsAF,(11,16) significant and clinically meaningful improvements in mental and physical health after cryoballoon ablation were observed.(17,18) Despite failing the primary endpoint, subjects with recurrence reported signif…”
Result
Cited by
Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
Reddy, V. Y., Gerstenfeld, E. P., Natale, A., Whang, W., Cuoco, F. A., Patel, C., Mountantonakis, S. E., Gibson, D. N., Harding, J. D., Ellis, C. R., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307291 · Cited by 970
Self-citationPulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial
Verma, A., Haines, D. E., Boersma, L. V., Sood, N., Natale, A., Marchlinski, F. E., Calkins, H., Sanders, P., Packer, D. L., Kuck, K.-H., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.063988 · Cited by 613
Self-citation
Metadata
- Authors
- Su, W. W., Reddy, V. Y., Bhasin, K., Champagne, J., Sangrigoli, R. M., Braegelmann, K. M., Kueffer, F. J., Novak, P., Gupta, S. K., Yamane, T., & Calkins, H.
- Venue
- Heart Rhythm
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 17
- Issue
- 11
- Pages
- 1841-1847
- ISSN
- 1547-5271 (ISSN-L)
- OpenAlex
- W3036666930
- Cited by
- 166
- References
- 3
- FWCI
- 13.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.